Preliminary experiments point out conolidine could inhibit precise ion channels, lowering neuronal excitability and limiting suffering alerts. This mechanism is particularly appropriate in neuropathic suffering, wherever irregular signaling causes persistent distress. Furthermore, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to pain perception. Comp... https://mariaho268pmg6.wikisona.com/user